Cargando...
Ipratropium bromide versus long‐acting beta‐2 agonists for stable chronic obstructive pulmonary disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with long acting beta‐2 agonists (LABAs) and anticholinergic bronchodilator medications, both of which are recomm...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2006
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7200053/ https://ncbi.nlm.nih.gov/pubmed/16856113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006101 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|